Literature DB >> 12166828

Amyloid beta-peptide promotes permeability transition pore in brain mitochondria.

P I Moreira1, M S Santos, A Moreno, C Oliveira.   

Abstract

In this work the effect of the neurotoxic amino acid sequence, Abeta25-35, on brain mitochondrial permeability transition pore (PTP) was studied. For the purpose, the mitochondrial transmembrane potential (deltapsim), mitochondrial respiration and the calcium fluxes were examined. It was observed that Abeta25-35, in the presence of Ca2+, decreased the deltapsim, the capacity of brain mitochondria to accumulate calcium and led to a complete uncoupling of the respiration. However, the reverse sequence of the peptide Abeta25-35 (Abeta35-25) did not promote the PTP. The alterations promoted by Abeta35-25 and/or Ca2+ could be reversed when Ca2 was removed by EGTA or when ADP plus oligomycin were present. The pretreatment with CsA or ADP plus oligomycin prevented the deltapsim drop and preserved the capacity of mitochondria to accumulate Ca2+. These results suggest that Abeta25-35 can promote the PTP induced by Ca2+.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12166828     DOI: 10.1023/a:1015536808304

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  48 in total

Review 1.  Calcium and mitochondrial reactive oxygen species generation: how to read the facts.

Authors:  Vera Adam-Vizi; Anatoly A Starkov
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Amyloid-beta-induced mitochondrial dysfunction.

Authors:  John Xi Chen; Shi Du Yan
Journal:  J Alzheimers Dis       Date:  2007-09       Impact factor: 4.472

3.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

Authors:  P Hemachandra Reddy; M Flint Beal
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

Review 4.  Current and emerging drug treatment options for Alzheimer's disease: a systematic review.

Authors:  Nathan Herrmann; Sarah A Chau; Ida Kircanski; Krista L Lanctôt
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

5.  Negative Conditioning of Mitochondrial Dysfunction in Age-related Neurodegenerative Diseases.

Authors:  Sharmelee Selvaraji; Luting Poh; Venkateswaran Natarajan; Karthik Mallilankaraman; Thiruma V Arumugam
Journal:  Cond Med       Date:  2019-02

Review 6.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

8.  Targeted polyphosphatase expression alters mitochondrial metabolism and inhibits calcium-dependent cell death.

Authors:  Andrey Y Abramov; Cresson Fraley; Catherine T Diao; Robert Winkfein; Michael A Colicos; Michael R Duchen; Robert J French; Evgeny Pavlov
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

9.  Neuroprotective effect of H. perforatum extracts on beta-amyloid-induced neurotoxicity.

Authors:  Bruno A Silva; Alberto C P Dias; Federico Ferreres; João O Malva; Catarina R Oliveira
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 10.  Autophagy in load-induced heart disease.

Authors:  Beverly A Rothermel; Joseph A Hill
Journal:  Circ Res       Date:  2008-12-05       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.